PTCT PTC Therapeutics, Inc.

Fundamentals / CIK 0001070081 / USD

PTC Therapeutics, Inc. reported $1.16B in revenue and a net loss of $106.0M for the trailing twelve months ended September 30, 2026 (up 69.6% year over year), with a 12.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PTCT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.77B$886.0M$0-$733.0MFY 2016 Revenue: $82.70MFY 2016 Net Income: -$142.1M2016FY 2017 Revenue: $194.4MFY 2017 Net Income: -$79.00M2017FY 2018 Revenue: $264.7MFY 2018 Net Income: -$128.1M2018FY 2019 Revenue: $307.0MFY 2019 Net Income: -$251.6M2019FY 2020 Revenue: $380.8MFY 2020 Net Income: -$438.2M2020FY 2021 Revenue: $538.6MFY 2021 Net Income: -$523.9M2021FY 2022 Revenue: $698.8MFY 2022 Net Income: -$559.0M2022FY 2023 Revenue: $937.8MFY 2023 Net Income: -$626.6M2023FY 2024 Revenue: $806.8MFY 2024 Net Income: -$363.3M2024FY 2025 Revenue: $1.73BFY 2025 Net Income: $682.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.73B $806.8M $937.8M $698.8M $538.6M $380.8M $307.0M $264.7M $194.4M $82.70M
Cost of Revenue -- -- -- -- -- -- $12.13M $12.67M $4.58M $0
Gross Profit -- -- -- -- -- -- $294.8M $252.1M $189.8M $82.70M
Research & Development $455.2M $534.5M $666.6M $651.5M $540.7M $477.6M $257.5M $172.0M $117.5M $117.6M
Selling, General & Admin $347.1M $300.9M $332.5M $326.0M $285.8M $245.2M $202.5M $153.5M $121.3M $97.13M
Total Operating Expenses $863.7M $1.11B $1.38B $1.15B $913.0M $812.5M $548.1M $380.4M $258.7M $214.8M
Operating Income $866.9M -$302.6M -$439.5M -$447.4M -$374.4M -$431.8M -$241.2M -$115.7M -$64.29M -$132.1M
EBITDA $905.8M -$226.9M -$202.9M -$318.6M -$310.3M -$388.3M -$209.0M -$89.60M -$46.61M -$128.8M
Income Before Tax $696.6M -$363.1M -$696.1M -$587.5M -$518.3M -$402.9M -$239.9M -$128.1M -$77.67M -$141.5M
Income Tax Expense $13.97M $176K -$69.51M -$28.47M $5.56M $35.23M $11.65M -$29K $1.33M $569K
Net Income $682.6M -$363.3M -$626.6M -$559.0M -$523.9M -$438.2M -$251.6M -$128.1M -$79.00M -$142.1M
Basic EPS $8.58 -$4.73 -$8.37 -$7.79 -$7.43 -$6.64 -$4.27 -$2.75 -$2.02 -$4.17
Diluted EPS $7.78 -$4.73 -$8.37 -$7.79 -$7.43 -$6.64 -$4.27 -$2.75 -$2.02 -$4.17
Basic Shares Outstanding 79.5M 76.8M 74.8M 71.7M 70.5M 66.0M 58.9M 46.6M 39.2M 34.0M
Diluted Shares Outstanding 88.3M 76.8M 74.8M 71.7M 70.5M 66.0M 58.9M 46.6M 39.2M 34.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $357.8M $360.5M $272.6M $164.7M $211.0M $178.9M $1.18B $213.2M
Research & Development $105.4M $99.15M $100.9M $133.1M $100.2M $113.0M $109.0M $124.8M
Selling, General & Admin $80.08M $80.63M $86.18M $96.87M $84.05M $85.26M $80.96M $84.68M
Total Operating Expenses $332.7M $211.5M $227.6M $236.0M $208.0M $213.8M $205.9M $375.6M
Operating Income $25.11M $149.0M $44.96M -$71.35M $3.02M -$34.96M $970.2M -$162.4M
EBITDA $41.93M $164.9M $60.37M -$58.45M $14.12M -$27.37M $977.4M -$155.6M
Income Before Tax -$41.09M $97.55M -$2.46M -$139.1M -$23.07M -$71.05M $929.8M -$94.70M
Income Tax Expense $10.61M $14.05M $347K -$4.12M -$38.97M -$6.20M $63.27M -$28.81M
Net Income -$51.69M $83.50M -$2.81M -$135.0M $15.90M -$64.85M $866.6M -$65.89M
Basic EPS -$0.62 $1.01 -$0.03 -- $0.20 -$0.83 $11.09 --
Diluted EPS -$0.62 $0.92 -$0.03 -- $0.20 -$0.83 $10.04 --
Basic Shares Outstanding 83.5M 83.0M 82.5M -- 78.5M 78.2M 78.1M --
Diluted Shares Outstanding 83.5M 92.0M 82.5M -- 87.1M 78.2M 86.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $984.6M $779.7M $594.0M $279.8M $189.7M $208.8M $288.0M $169.5M $111.8M $58.32M
Short-Term Investments $960.7M $360.0M $282.7M $130.9M $583.7M $894.8M $398.5M $58.09M $79.45M $173.3M
Cash & Short-Term Investments $1.95B $1.14B $876.7M $410.7M $773.4M $1.10B $686.6M $227.6M $191.2M $231.7M
Accounts Receivable, Net $181.6M $158.6M $160.8M $155.6M $110.5M $69.93M $55.54M $67.91M $40.39M $24.93M
Inventory $79.65M $23.19M $30.58M $21.81M $15.86M $18.70M $19.29M $16.12M $10.75M $0
Total Current Assets $2.27B $1.37B $1.22B $693.8M $954.4M $1.23B $779.3M $320.9M $249.1M $261.3M
Property, Plant & Equipment, Net $55.37M $60.97M $87.09M $72.59M $52.59M $33.83M $21.55M $12.69M $8.38M $7.43M
Goodwill $82.34M $82.34M $82.34M $82.34M $82.34M $82.34M $82.34M $82.34M $0 --
Intangible Assets $388.8M $118.8M $379.5M $705.9M $724.8M $715.3M $710.5M $701.0M $133.0M $0
Total Non-Current Assets $624.8M $339.5M $677.1M $1.01B $983.7M $976.5M $844.5M $798.4M $142.6M $8.06M
Total Assets $2.90B $1.71B $1.90B $1.71B $1.94B $2.21B $1.62B $1.12B $391.7M $269.3M
Accounts Payable $45.49M $17.27M $6.04M $27.27M $23.03M $18.66M $10.32M $6.00M $15.28M $6.30M
Short-Term Debt $286.6M -- -- -- $149.5M -- $20.00M $11.67M $0 --
Deferred Revenue (Current) $2.04M $5.50M $801K $1.35M -- $4.15M $8.24M $3.72M $3.94M $0
Other Current Liabilities -- -- -- -- $1.46M $1.25M $3.19M $3.81M $1.67M $865K
Total Current Liabilities $968.4M $581.0M $603.1M $406.2M $509.3M $277.3M $235.9M $166.8M $82.05M $49.62M
Long-Term Debt -- $285.4M $284.2M $571.7M $281.9M $309.1M $293.9M $141.3M $145.0M $98.22M
Deferred Revenue (Non-Current) -- -- -- -- -- -- $3.42M $9.72M $7.95M $1.59M
Other Non-Current Liabilities $13.70M $21.43M $141K $2.64M -- $1.39M $141K $58K $243K $335K
Total Non-Current Liabilities $2.14B $2.22B $2.11B $1.65B $1.43B $1.45B $793.6M $601.7M $153.2M $100.1M
Total Liabilities $3.10B $2.80B $2.71B $2.05B $1.94B $1.73B $1.03B $768.5M $235.2M $149.8M
Total Debt (incl. Leases) $398.7M $389.3M $415.0M $703.6M $535.4M $420.4M $328.0M $153.0M $145.0M $98.22M
Common Stock $80K $77K $75K $72K $71K $70K $62K $51K $42K $34K
Retained Earnings -$2.96B -$3.65B -$3.28B -$2.66B -$2.10B -$1.63B -$1.19B -$938.9M -$814.1M -$735.1M
Accumulated Other Comp. Income $10.50M -$25.89M -$1.28M $4.80M -$24.28M -$60.96M -$10.58M $1.46M $3.97M -$1.49M
Total Stockholders' Equity -$205.3M -$1.10B -$818.6M -$347.1M $1.44M $482.0M $594.3M $350.7M $156.4M $119.6M
Total Equity -$205.3M -$1.10B -$818.6M -$347.1M $1.44M $482.0M $594.3M $350.7M $156.4M -$1.49M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $508.9M $1.05B $834.0M $984.6M $672.6M $1.02B $1.48B $779.7M
Short-Term Investments $1.62B $1.18B $1.06B $960.7M $1.02B $971.8M $547.0M $360.0M
Cash & Short-Term Investments $2.13B $2.23B $1.89B $1.95B $1.69B $1.99B $2.03B $1.14B
Accounts Receivable, Net $238.1M $239.0M $219.9M $181.6M $203.1M $196.1M $210.5M $158.6M
Inventory $109.3M $91.35M $75.57M $79.65M $52.69M $34.06M $21.68M $23.19M
Total Current Assets $2.54B $2.62B $2.25B $2.27B $2.01B $2.27B $2.32B $1.37B
Property, Plant & Equipment, Net $49.33M $51.49M $52.74M $55.37M $56.97M $57.19M $59.46M $60.97M
Goodwill $82.34M $82.34M $82.34M $82.34M $82.34M $82.34M $82.34M $82.34M
Intangible Assets $443.7M $402.9M $380.7M $388.8M $396.5M $143.8M $118.4M $118.8M
Total Non-Current Assets $669.9M $633.1M $615.1M $624.8M $635.9M $361.3M $339.0M $339.5M
Total Assets $3.21B $3.25B $2.87B $2.90B $2.64B $2.63B $2.66B $1.71B
Accounts Payable $41.59M $40.45M $25.48M $45.49M $36.62M $26.50M $15.15M $17.27M
Short-Term Debt -- $55.45M $286.9M $286.6M $286.3M -- -- --
Deferred Revenue (Current) $1.98M $1.19M $498K $2.04M $1.69M $9.76M $12.83M $5.50M
Total Current Liabilities $776.1M $771.1M $923.6M $968.4M $866.2M $627.8M $595.4M $581.0M
Long-Term Debt $536.3M $535.5M -- -- -- $286.0M $285.7M $285.4M
Other Non-Current Liabilities $14.50M $14.50M $13.70M $13.70M $2.58M $7.82M $22.43M $21.43M
Total Non-Current Liabilities $2.62B $2.64B $2.13B $2.14B $1.93B $2.21B $2.25B $2.22B
Total Liabilities $3.40B $3.42B $3.05B $3.10B $2.80B $2.84B $2.84B $2.80B
Total Debt (incl. Leases) $636.0M $696.5M $395.1M $398.7M $410.1M $388.2M $389.6M $389.3M
Common Stock $82K $82K $81K $80K $79K $78K $78K $77K
Retained Earnings -$2.94B -$2.88B -$2.97B -$2.96B -$2.83B -$2.85B -$2.78B -$3.65B
Accumulated Other Comp. Income $2.55M $6.02M $8.47M $10.50M $5.93M $7.36M -$13.95M -$25.89M
Total Stockholders' Equity -$191.2M -$165.4M -$180.5M -$205.3M -$155.8M -$206.5M -$185.8M -$1.10B
Total Equity -$191.2M -$165.4M -$180.5M -$205.3M -$155.8M -$206.5M -$185.8M -$1.10B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $682.6M -$363.3M -$626.6M -$559.0M -$523.9M -$438.2M -$251.6M -$128.1M -$79.00M -$142.1M
Depreciation & Amortization $38.81M $75.66M $236.6M $128.8M $64.13M $43.49M $32.18M $26.09M $17.68M $3.29M
Stock-Based Compensation $74.55M $74.61M $101.6M $110.3M $103.5M $70.33M $42.13M $33.25M $30.56M $35.01M
Change in Receivables -$10.15M $1.73M -$1.54M -$48.47M -$44.99M -$10.48M $11.53M -$29.59M -$12.20M -$14.84M
Change in Inventory -$53.90M $6.16M -$8.18M -$6.67M $1.80M $1.84M -$3.46M -$5.82M -$6.45M $0
Operating Cash Flow $711.2M -$107.7M -$158.4M -$356.7M -$251.3M -$194.1M -$98.64M -$27.64M -$10.06M -$103.6M
Capital Expenditure -$8.86M -$6.50M -$28.44M -$32.02M -$28.21M -$17.84M -$13.76M -$7.10M -$3.10M -$1.78M
Free Cash Flow $702.3M -$114.2M -$186.9M -$388.7M -$279.5M -$211.9M -$112.4M -$34.74M -$13.16M -$105.3M
Acquisitions, Net -- -- -- -- -- -- $0 -$48.89M $0 $0
Purchases of Investments -$1.36B -$608.0M -$174.1M -$52.76M -$333.1M -$1.44B -$494.1M -$68.61M -$81.37M -$85.38M
Investing Cash Flow -$862.0M $44.18M -$176.7M $290.2M $219.2M -$561.5M -$387.2M -$42.61M $13.12M $104.5M
Common Stock Issued -- -- -- -- -- $28.09M $323.8M $117.9M $0 $0
Financing Cash Flow $331.1M $255.9M $646.4M $168.0M $20.88M $668.7M $613.2M $131.6M $44.22M $968K
Net Change in Cash $203.0M $185.0M $314.4M $98.71M -$19.09M -$79.22M $126.0M $57.71M $53.47M $299K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$51.69M $83.50M -$2.81M -$135.0M $15.90M -$64.85M $866.6M -$65.89M
Depreciation & Amortization $16.82M $15.87M $15.41M $12.90M $11.11M $7.58M $7.22M $6.76M
Stock-Based Compensation $23.83M $23.29M $23.42M $18.52M $19.43M $18.54M $18.06M $17.24M
Change in Receivables $42K -$19.73M -$40.39M $22.21M -$6.47M $21.90M -$47.79M $40.76M
Change in Inventory -$18.11M -$15.86M $2.64M -$26.78M -$18.53M -$10.78M $2.19M $11.09M
Operating Cash Flow -$25.31M $129.1M -$59.04M -$34.27M -$66.30M -$58.33M $870.1M -$30.00M
Capital Expenditure -$2.66M -$2.19M -$1.20M -$2.37M -$3.52M -$1.25M -$1.72M -$3.77M
Free Cash Flow -$27.97M $126.9M -$60.24M -$36.65M -$69.82M -$59.58M $868.4M -$33.77M
Purchases of Investments -$753.2M -$467.0M -$454.7M -$312.3M -$204.1M -$524.8M -$322.3M -$131.3M
Investing Cash Flow -$442.4M -$122.6M -$93.74M $34.01M -$289.6M -$422.0M -$184.4M $267.7M
Financing Cash Flow -$73.24M $211.9M $6.40M $302.5M $15.22M $3.96M $9.41M $26.47M
Net Change in Cash -$541.0M $215.9M -$147.9M $312.0M -$346.8M -$462.8M $700.5M $255.5M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- 96.0% 95.2% 97.6% 100.0%
Operating Margin 50.1% -37.5% -46.9% -64.0% -69.5% -113.4% -78.6% -43.7% -33.1% -159.7%
Net Profit Margin 39.4% -45.0% -66.8% -80.0% -97.3% -115.1% -82.0% -48.4% -40.6% -171.8%
Return on Equity (ROE) -- -- -- -- -36432.6% -90.9% -42.3% -36.5% -50.5% -118.8%
Return on Assets (ROA) 23.5% -21.3% -33.1% -32.8% -27.0% -19.8% -15.5% -11.4% -20.2% -52.8%
Current Ratio 2.35x 2.35x 2.02x 1.71x 1.87x 4.44x 3.30x 1.92x 3.04x 5.27x
Quick Ratio 2.27x 2.31x 1.97x 1.65x 1.84x 4.37x 3.22x 1.83x 2.90x 5.27x
Debt to Equity -- -- -- -- 372.31x 0.87x 0.55x 0.44x 0.93x 0.82x
Revenue Growth (YoY) +114.5% -14.0% +34.2% +29.7% +41.4% +24.0% +16.0% +36.2% +135.0% +124.9%
Gross Profit Growth (YoY) -- -- -- -- -- -- +17.0% +32.8% +129.5% +124.9%
5Y Revenue / Share Growth +277.3% +101.3% +120.5% +96.4% +214.6% +427.4% +552.1% +110.2% -100.0% -100.0%
10Y Revenue / Share Growth +1890.2% +1212.7% +363.4% -99.9% -100.0% -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -- -- -100.0%
10Y Net Income / Share Growth -- -- -- -- -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 12.8% 12.5% -7.1% 50.1% 43.6% 40.7% 40.2% -37.5%
Net Profit Margin -9.2% -3.8% -22.6% 39.4% 42.3% 35.6% 33.6% -45.0%
Return on Assets (ROA) -3.3% -1.2% -6.5% 23.5% 28.4% 23.9% 22.4% -21.3%
Current Ratio 3.27x 3.39x 2.44x 2.35x 2.32x 3.62x 3.89x 2.35x
Quick Ratio 3.13x 3.28x 2.36x 2.27x 2.26x 3.57x 3.85x 2.31x
Revenue Growth (YoY) +69.6% +101.5% -76.8% -22.7% +7.2% -4.2% +459.7% -30.6%
Operating Income Growth (YoY) +732.7% -- -95.4% -- -- -- -- -2890.2%
Net Income Growth (YoY) -425.2% -- -100.3% -- -- -- -- --
EPS Growth (YoY) -410.0% -- -100.3% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -106.8% -- -- -- +1129.6% --
Free Cash Flow Growth (YoY) -- -- -106.9% -- -- -- +1319.5% --
Source: SEC EDGAR CompanyFacts (CIK 0001070081) · from December 31, 2011 Data through September 30, 2026 · synced Nov 20, 2026, 05:15 UTC · Open in terminal